SINGAPORE--(Marketwired - Aug 10, 2015) - Phorm Corporation Limited (
Phorm Corporation Limited
("Phorm" or the "Company")
Notice of Annual General Meeting
Phorm (
The formal notice convening and outlining details of the AGM is being posted to shareholders today and, once posted, will also be made available to download from the Investor Relations section of the Company's website at www.phorm.com.
Phorm also announces that its registered office address has been changed with immediate effect to 38 Beach Road, #29-11 South Beach Tower, Singapore 189767.
For further information please contact: | |
Phorm Corporation Limited | |
Timothy Smith (analysts and investors) | +44 20 3397 6001 |
Mirabaud Securities LLP (Broker) | +44 20 7321 2508 |
Jason Woollard | |
Peter Krens | |
Strand Hanson Limited (Nominated Adviser) | +44 20 7409 3494 |
James Harris | |
Matthew Chandler | |
James Dance | |
About Phorm
Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.
Phorm's industry leading technology enables its Internet Service Provider ("ISP") partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.
Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.
Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.
Phorm, under a predecessor holding company, was admitted to trading on the AIM market of the London Stock Exchange in 2004.
For more information, please visit: www.phorm.com
This information is provided by RNS
The company news service from the London Stock Exchange
Contact Information:
RNS
Customer
Services
0044-207797-4400
rns@londonstockexchange.com
http://www.rns.com